Top Legislation - View All
Also tagged in: Access to health care, Administrative procedure, Administrative remedies, Aged, Congressional reporting requirements, Department of Health and Human Services, DNA, Evidence (Law), Federal advisory bodies, Government information, Government paperwork, Government publicity, Health policy, Law, Medical care, Medical fees, Medical laboratories, Medical tests, Medicare, Medicine, Molecular biology, Science policy
Latest Action: 03/13/2007 - Referred to the Subcommittee on Health. Bill TextTo amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule. 3/5/2007--Introduced. Medicare Advanced Laboratory Diagnostics Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act with respect to: (1) correction of erroneous determinations and other changes in fee schedule and national limitation amounts for clinical diagnostic laboratory tests; (2) issuance of regulations on gap-filling methodology in determining the Medicare fee schedule for such tests; (3) increased transparency of the process for determining fee schedule amounts for new tests; and (4) mandatory advance notice of clinical diagnostic laboratory test amounts being considered for adjustment under inherent reasonableness authority. Directs the Secretary to: (1) establish a demonstration project to evaluate new approaches to coding and payment under the Medicare program for clinical diagnostic laboratory tests; and (2) appoint [...] show full description
Also tagged in: Agriculture, Agriculture in foreign trade, Dairy products, Food, Foreign policy, Import restrictions, International affairs, Milk, Reciprocity, Tariff, Tariff agreements, Tariff preferences, Trade, Trade agreements
Latest Action: 05/24/2007 - Read twice and referred to the Committee on Finance. Bill TextA bill to impose tariff-rate quotas on certain casein and milk protein concentrates. 5/24/2007--Introduced. Milk Import Tariff Equity Act - Amends the Harmonized Tariff Schedule of the United States to impose tariff-rate quotas (quantitative import limits) and provide various duty rates on certain casein, caseinates, milk protein concentrate, and other casein derivatives and glues imported into the United States (except imports from Mexico). Authorizes the President to: (1) enter into a trade agreement with a foreign country to grant new concessions as compensation in order to maintain the general level of reciprocal and mutually advantageous concessions; and (2) proclaim any necessary modification or continuance of any existing duty, or continuance of existing duty-free or excise treatment, or any quantitative limitation. Sets forth certain limits on the reduction of duties on such products.
Also tagged in: Biotechnology, Business, Congressional reporting requirements, Consumers, Deceptive advertising, Drug approvals, Drug industry, Drugs, Executive departments, Federal advisory bodies, Health policy, Labeling, Licenses, Medical care, Medicine, Technology
Latest Action: 04/20/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to provide for the approval of similar biological products, and for other purposes. 4/19/2007--Introduced. Patient Protection and Innovative Biologic Medicines Act of 2007 - Amends the Public Health Service Act to allow any person to submit an application for approval of a biologics license for a biological product that is claimed to be similar to a qualified biological product (reference product) after 12 years have elapsed since the reference product was approved or licensed.Allows the Secretary of Health and Human Services to approve such a similar biological product: (1) only if the applicant demonstrates that the product conforms to the applicable final product-class specific guidance and the Secretary concludes the product is safe, pure, and potent; (2) only for indications for which the reference product is approved; and (3) to be effective only after at least 14 years have elapsed since the reference product was approved [...] show full description
Also tagged in: Administrative procedure, Agriculture, Business, Consumers, Dairy industry, Dairy products, Department of Health and Human Services, Executive departments, Farmers, Food, Food and Drug Administration (FDA), Food labeling, Labeling, Law, Milk
Latest Action: 02/08/2007 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry. (text of measure as introduced: CR S1786) Bill TextA bill to prohibit products that contain dry ultra-filtered milk products, milk protein concentrate, or casein from being labeled as domestic natural cheese, and for other purposes. 2/8/2007--Introduced. Quality Cheese Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the Commissioner of the Food and Drug Administration from using federal funds to amend specified regulations to include dry ultra-filtered milk, milk protein concentrate, or casein in the definition of "milk" or "nonfat milk" as specified in the domestic natural standards for cheese and cheese products.
Also tagged in: Birth defects, Blood diseases, Budgets, Cancer, Child health, Children, Clinics, Commemorations, Congressional tributes, Data banks, Directories, Federal aid to health facilities, Federal aid to research, Foundations, Health education, Health information systems, Health policy, Hereditary diseases, Hospitals, Laboratories, Medical care, Medical centers, Medical records, Medical research, Medicine, Research centers, Science policy, Social services, Technology
Latest Action: 10/15/2007 - Ms. Baldwin moved to suspend the rules and agree to the resolution, as amended. Bill TextExpressing the sense of the House of Representatives with respect to Diamond-Blackfan Anemia. 10/15/2007--Passed House amended. (There is 1 other summary) Recognizes: (1) the value of the identification of Diamond-Blackfan Anemia (DBA) in identifying implications of cancer predisposition and understanding human development and the molecular basis for certain birth defects; and (2) the importance of centers providing complete care and treatment leading to an increase in correct and early diagnosis.Commends: (1) Schneider Children's Hospital for providing the first DBA Comprehensive Clinical Care Center and developing the DBA Patient Registry; and (2) the Daniella Maria Arturi Foundation and the Diamond-Blackfan Anemia Foundation for their efforts to facilitate collaboration among the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to achieve a successful multidisciplinary approach aimed at shortening [...] show full description
Also tagged in: Access to health care, Administrative procedure, Administrative remedies, Aged, Congressional reporting requirements, Department of Health and Human Services, DNA, Federal advisory bodies, Government information, Government paperwork, Government publicity, Health policy, Medical care, Medical fees, Medical laboratories, Medical tests, Medicare, Medicine, Molecular biology, Science policy
Latest Action: 12/03/2007 - Read twice and referred to the Committee on Finance. Bill TextA bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule. 12/3/2007--Introduced. Medicare Advanced Laboratory Diagnostics Act of 2007 - Directs the Secretary of Health and Human Services to: (1) establish a demonstration project to evaluate new approaches to coding and payment under the Medicare program (title XVIII of the Social Security Act (SSA)) for clinical diagnostic laboratory tests; and (2) appoint a standing panel to determine tests to be included in the project and make recommendations derived from project results to the Secretary of Health and Human Services. Amends SSA title XVIII with respect to: (1) correction of erroneous determinations and other changes in fee schedule and national limitation amounts for clinical diagnostic laboratory tests; (2) issuance of regulations on gap-filling methodology in determining the Medicare fee schedule for such tests; (3) increased transparency of [...] show full description
|
Latest Legislation - View All
Also tagged in: Access to health care, Administrative procedure, Administrative remedies, Aged, Congressional reporting requirements, Department of Health and Human Services, DNA, Federal advisory bodies, Government information, Government paperwork, Government publicity, Health policy, Medical care, Medical fees, Medical laboratories, Medical tests, Medicare, Medicine, Molecular biology, Science policy
Latest Action: 12/03/2007 - Read twice and referred to the Committee on Finance. Bill TextA bill to amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule. 12/3/2007--Introduced. Medicare Advanced Laboratory Diagnostics Act of 2007 - Directs the Secretary of Health and Human Services to: (1) establish a demonstration project to evaluate new approaches to coding and payment under the Medicare program (title XVIII of the Social Security Act (SSA)) for clinical diagnostic laboratory tests; and (2) appoint a standing panel to determine tests to be included in the project and make recommendations derived from project results to the Secretary of Health and Human Services. Amends SSA title XVIII with respect to: (1) correction of erroneous determinations and other changes in fee schedule and national limitation amounts for clinical diagnostic laboratory tests; (2) issuance of regulations on gap-filling methodology in determining the Medicare fee schedule for such tests; (3) increased transparency of [...] show full description
Also tagged in: Birth defects, Blood diseases, Budgets, Cancer, Child health, Children, Clinics, Commemorations, Congressional tributes, Data banks, Directories, Federal aid to health facilities, Federal aid to research, Foundations, Health education, Health information systems, Health policy, Hereditary diseases, Hospitals, Laboratories, Medical care, Medical centers, Medical records, Medical research, Medicine, Research centers, Science policy, Social services, Technology
Latest Action: 10/15/2007 - Ms. Baldwin moved to suspend the rules and agree to the resolution, as amended. Bill TextExpressing the sense of the House of Representatives with respect to Diamond-Blackfan Anemia. 10/15/2007--Passed House amended. (There is 1 other summary) Recognizes: (1) the value of the identification of Diamond-Blackfan Anemia (DBA) in identifying implications of cancer predisposition and understanding human development and the molecular basis for certain birth defects; and (2) the importance of centers providing complete care and treatment leading to an increase in correct and early diagnosis.Commends: (1) Schneider Children's Hospital for providing the first DBA Comprehensive Clinical Care Center and developing the DBA Patient Registry; and (2) the Daniella Maria Arturi Foundation and the Diamond-Blackfan Anemia Foundation for their efforts to facilitate collaboration among the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to achieve a successful multidisciplinary approach aimed at shortening [...] show full description
Also tagged in: Agriculture, Agriculture in foreign trade, Dairy products, Food, Foreign policy, Import restrictions, International affairs, Milk, Reciprocity, Tariff, Tariff agreements, Tariff preferences, Trade, Trade agreements
Latest Action: 05/24/2007 - Read twice and referred to the Committee on Finance. Bill TextA bill to impose tariff-rate quotas on certain casein and milk protein concentrates. 5/24/2007--Introduced. Milk Import Tariff Equity Act - Amends the Harmonized Tariff Schedule of the United States to impose tariff-rate quotas (quantitative import limits) and provide various duty rates on certain casein, caseinates, milk protein concentrate, and other casein derivatives and glues imported into the United States (except imports from Mexico). Authorizes the President to: (1) enter into a trade agreement with a foreign country to grant new concessions as compensation in order to maintain the general level of reciprocal and mutually advantageous concessions; and (2) proclaim any necessary modification or continuance of any existing duty, or continuance of existing duty-free or excise treatment, or any quantitative limitation. Sets forth certain limits on the reduction of duties on such products.
Also tagged in: Biotechnology, Business, Congressional reporting requirements, Consumers, Deceptive advertising, Drug approvals, Drug industry, Drugs, Executive departments, Federal advisory bodies, Health policy, Labeling, Licenses, Medical care, Medicine, Technology
Latest Action: 04/20/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to provide for the approval of similar biological products, and for other purposes. 4/19/2007--Introduced. Patient Protection and Innovative Biologic Medicines Act of 2007 - Amends the Public Health Service Act to allow any person to submit an application for approval of a biologics license for a biological product that is claimed to be similar to a qualified biological product (reference product) after 12 years have elapsed since the reference product was approved or licensed.Allows the Secretary of Health and Human Services to approve such a similar biological product: (1) only if the applicant demonstrates that the product conforms to the applicable final product-class specific guidance and the Secretary concludes the product is safe, pure, and potent; (2) only for indications for which the reference product is approved; and (3) to be effective only after at least 14 years have elapsed since the reference product was approved [...] show full description
Also tagged in: Access to health care, Administrative procedure, Administrative remedies, Aged, Congressional reporting requirements, Department of Health and Human Services, DNA, Evidence (Law), Federal advisory bodies, Government information, Government paperwork, Government publicity, Health policy, Law, Medical care, Medical fees, Medical laboratories, Medical tests, Medicare, Medicine, Molecular biology, Science policy
Latest Action: 03/13/2007 - Referred to the Subcommittee on Health. Bill TextTo amend title XVIII of the Social Security Act to improve payments under the Medicare clinical laboratory fee schedule. 3/5/2007--Introduced. Medicare Advanced Laboratory Diagnostics Act of 2007 - Amends title XVIII (Medicare) of the Social Security Act with respect to: (1) correction of erroneous determinations and other changes in fee schedule and national limitation amounts for clinical diagnostic laboratory tests; (2) issuance of regulations on gap-filling methodology in determining the Medicare fee schedule for such tests; (3) increased transparency of the process for determining fee schedule amounts for new tests; and (4) mandatory advance notice of clinical diagnostic laboratory test amounts being considered for adjustment under inherent reasonableness authority. Directs the Secretary to: (1) establish a demonstration project to evaluate new approaches to coding and payment under the Medicare program for clinical diagnostic laboratory tests; and (2) appoint [...] show full description
Also tagged in: Administrative procedure, Agriculture, Business, Consumers, Dairy industry, Dairy products, Department of Health and Human Services, Executive departments, Farmers, Food, Food and Drug Administration (FDA), Food labeling, Labeling, Law, Milk
Latest Action: 02/08/2007 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry. (text of measure as introduced: CR S1786) Bill TextA bill to prohibit products that contain dry ultra-filtered milk products, milk protein concentrate, or casein from being labeled as domestic natural cheese, and for other purposes. 2/8/2007--Introduced. Quality Cheese Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the Commissioner of the Food and Drug Administration from using federal funds to amend specified regulations to include dry ultra-filtered milk, milk protein concentrate, or casein in the definition of "milk" or "nonfat milk" as specified in the domestic natural standards for cheese and cheese products.
|
